e Company News, China Resources Shuanghe (600062) announced on the evening of November 1 that its wholly-owned subsidiary, CR SECCO, received amlodipine atorvastatin calcium issued by the State Drug Administration...
11-04
On November 1, China Resources Shuanghe (600062.SH) announced that recently, the company's wholly-owned subsidiary, China Resources SECCO Pharmaceutical Co., Ltd. ("CR SECCO") received...
11-04
On October 30, China Resources Shuanghe (600062) released the first three quarters of 2021 report, during the reporting period, the company achieved operating income of 6,875,302,88...
11-04
Recently, Cr Resources Shuanghe and the American Lind Pharmaceutical Company reached an agreement to jointly develop an oral small molecule RNA polymerization for the treatment of novel coronavirus pneumonia COVID-19...
11-04
China Resources Pharmaceutical (03320) announced the results of China Resources Shuanghe (600062.SH) for the 9 months ended September 30, 2021, and was released in 202...
11-01
On October 31, 2021, China Resources Shuanghe (600062.SH) released the third quarter report of 2021, achieving operating income of 2.245 billion yuan, an increase of 0.8% year-on-year.
10-31
On October 16, the ShuangheHu south station of Zhengxu Municipal Railway, which was built by the First Bureau of China Railway, successfully passed the decoration and the acceptance of the first piece of mechanical and electrical engineering, which played a good leading role in the implementation of the first project of all majors on the whole line.
10-27
2021-08-30 China Resources Shuanghe (600062) issued an announcement: Other in 2021-08-26 to investigate our company, this survey by chairman Feng Yi, Dong ...
10-26
Nandu News On September 10, the board of directors of China Resources Shuanghe Pharmaceutical Co., Ltd. (600062) recently received the resignation report submitted by Guo Wei and Deng Ronghui, who were due to work arrangements...
10-26
On the evening of August 23, China Resources Shuanghe released its semi-annual report saying that its operating income in the first half of 2021 was about 4.63 billion yuan, an increase of 11.64% year-on-year. Attributed to the above...
10-26
On September 29, China Resources Shuanghe (600062.SH) announced that recently, China Resources Shuanghe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of China Resources Shuanghe Pharmaceutical Co., Ltd. (...
10-26
e Company News, China Resources Pharmaceutical Official Micro News, a few days ago, China Resources Shuanghe Innovation Division and the United StatesLigand Pharmaceutical Company (NASDAQ: LGND) reached an agreement, the two sides ...
10-26